Eric Wadman

434 total citations
14 papers, 252 citations indexed

About

Eric Wadman is a scholar working on Immunology, Organic Chemistry and Physiology. According to data from OpenAlex, Eric Wadman has authored 14 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Organic Chemistry and 4 papers in Physiology. Recurrent topics in Eric Wadman's work include Chemical Synthesis and Analysis (3 papers), Asthma and respiratory diseases (3 papers) and Chemokine receptors and signaling (3 papers). Eric Wadman is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Asthma and respiratory diseases (3 papers) and Chemokine receptors and signaling (3 papers). Eric Wadman collaborates with scholars based in United States, Germany and Sweden. Eric Wadman's co-authors include Carrie Brodmerkel, Paul Davies, Soo S. Ko, Joseph B. Santella, Carl P. Decicco, Robert Newton, Douglas G. Batt, Maryanne Covington, Rod Kunynetz and Dean A. Wacker and has published in prestigious journals such as Gastroenterology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Eric Wadman

14 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Wadman United States 10 88 74 53 53 48 14 252
Kristine Devito United States 10 97 1.1× 149 2.0× 34 0.6× 71 1.3× 94 2.0× 12 370
Steven C. Gilman United States 10 133 1.5× 37 0.5× 41 0.8× 93 1.8× 92 1.9× 15 364
Raquel S. Simón Spain 8 34 0.4× 22 0.3× 15 0.3× 34 0.6× 70 1.5× 26 257
Kirsten Roebrock Germany 7 109 1.2× 24 0.3× 26 0.5× 11 0.2× 134 2.8× 7 301
John Michael Kilpatrick United States 10 92 1.0× 22 0.3× 32 0.6× 47 0.9× 183 3.8× 11 427
H U Weltzien Germany 9 313 3.6× 49 0.7× 19 0.4× 50 0.9× 47 1.0× 10 487
Jacqueline Adam Switzerland 8 137 1.6× 74 1.0× 8 0.2× 37 0.7× 38 0.8× 11 521
L Y Pan China 7 31 0.4× 43 0.6× 45 0.8× 71 1.3× 146 3.0× 20 309
Nandadeep J. Jadhav India 6 89 1.0× 9 0.1× 102 1.9× 40 0.8× 60 1.3× 7 289

Countries citing papers authored by Eric Wadman

Since Specialization
Citations

This map shows the geographic impact of Eric Wadman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Wadman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Wadman more than expected).

Fields of papers citing papers by Eric Wadman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Wadman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Wadman. The network helps show where Eric Wadman may publish in the future.

Co-authorship network of co-authors of Eric Wadman

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Wadman. A scholar is included among the top collaborators of Eric Wadman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Wadman. Eric Wadman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Hayden, Karen, et al.. (2018). DOP014 Impact of genetic variation on gene and protein expression in Crohn’s disease. Journal of Crohn s and Colitis. 12(supplement_1). S039–S040. 1 indexed citations
3.
Wu, Yang‐Chang, Qingmin Wang, Michael Song, et al.. (2017). Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis. BMC Complementary and Alternative Medicine. 17(1). 439–439. 40 indexed citations
4.
Hayden, Karen, Eric Wadman, Sunita Bhagat, et al.. (2017). DOP052 Molecular response to ustekinumab in moderate-to-severe Crohn's disease by serum protein and biopsy gene expression analysis: results from Ustekinumab phase 3 studies. Journal of Crohn s and Colitis. 11(suppl_1). S57–S58. 2 indexed citations
5.
Monast, Calixte S., Marc A. Judson, Robert P. Baughman, et al.. (2017). Sarcoidosis extent relates to molecular variability. Clinical & Experimental Immunology. 188(3). 444–454. 13 indexed citations
6.
7.
Brodmerkel, Carrie, Eric Wadman, Richard G. Langley, et al.. (2013). Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.. PubMed. 12(10). 1122–9. 51 indexed citations
8.
Gardner, Daniel S., Joseph B. Santella, Andrew J. Tebben, et al.. (2007). From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(2). 586–595. 9 indexed citations
9.
Watson, Paul S., Bin Jiang, Maryanne Covington, et al.. (2006). 2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: Synthesis and selectivity. Bioorganic & Medicinal Chemistry Letters. 16(21). 5695–5699. 13 indexed citations
10.
Das, Anuk, Krishna Vaddi, Kimberly A. Solomon, et al.. (2006). Selective Inhibition of Eosinophil Influx into the Lung by Small Molecule CC Chemokine Receptor 3 Antagonists in Mouse Models of Allergic Inflammation. Journal of Pharmacology and Experimental Therapeutics. 318(1). 411–417. 30 indexed citations
11.
Batt, Douglas G., John Roderick, Joseph B. Santella, et al.. (2004). N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 787–791. 12 indexed citations
12.
Varnes, Jeffrey, Daniel S. Gardner, Joseph B. Santella, et al.. (2004). Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists. Bioorganic & Medicinal Chemistry Letters. 14(7). 1645–1649. 21 indexed citations
13.
Wacker, Dean A., Joseph B. Santella, Daniel S. Gardner, et al.. (2002). CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 12(13). 1785–1789. 35 indexed citations
14.
Wright, Stephen W., et al.. (1992). Novel 1-(pyridylphenyl)-1-phenyl-2-imidazolylethanols with topical antiinflammatory activity. Journal of Medicinal Chemistry. 35(17). 3148–3155. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristine Devito Breakdown of academic impact, for papers by Steven C. Gilman Breakdown of academic impact, for papers by Raquel S. Simón Breakdown of academic impact, for papers by Kirsten Roebrock Breakdown of academic impact, for papers by John Michael Kilpatrick Breakdown of academic impact, for papers by H U Weltzien Breakdown of academic impact, for papers by Jacqueline Adam Breakdown of academic impact, for papers by L Y Pan Breakdown of academic impact, for papers by Nandadeep J. Jadhav
Rankless by CCL
2026